Trial Parameters
Condition Glaucoma
Sponsor Montefiore Medical Center
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 142
Sex ALL
Min Age 30 Years
Max Age 100 Years
Start Date 2019-05-01
Completion 2028-06
Interventions
PilocarpinePrednisoloneOfloxacin
Brief Summary
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Eligibility Criteria
Inclusion Criteria: * Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider Exclusion Criteria: * Patients with previous history of eye surgeries (including laser procedures)
Related Trials
NCT02084745
Timing of Glaucoma Drainage Device With Boston Keratoprosthesis
View Trial →
NCT06492538
Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study
View Trial →
NCT06689696
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
View Trial →